Wegovy should be treating more than just obesity, ET HealthWorld
New Delhi: A new analysis found that the profound benefits of Novo Nordisk’s obesity drug Wegovy for people at risk of heart attacks or strokes don’t depend on the number of the scale-cardiovascular health improves whether people lose a lot or even very little weight. That message adds needed nuance to our understanding of the …